Novo nordisk patient assistance program

Instruct patients to check the label before each injection since accidental mix-ups with insulin containing products can occur. Steps for your patient to follow: Get emergency medical help if you have:

Uploader: Sajas
Date Added: 24 January 2012
File Size: 33.78 Mb
Operating Systems: Windows NT/2000/XP/2003/2003/7/8/10 MacOS 10/X
Downloads: 92087
Price: Free* [*Free Regsitration Required]

Fluid Retention and Congestive Heart Failure: Do not share your Levemir FlexTouch with other people, even if the needle has been changed. If heart failure develops, dosage reduction or discontinuation of the TZD must be considered.

Patient Assistance Programs

Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.

Monitor blood glucose in all patients treated with insulin. Select a valid page path.

If you need assistance with prescription costs, help may be available. Patient Assistance Program Forms. Some of these events have been reported in patients without known underlying renal noedisk.

Please click here for full Prescribing Information including Boxed Warning. Read the Instructions for Use and take exactly as directed.

Novo Nordisk Diabetes Patient Assistance Program - Insulin

Use in Specific Pstient. These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. Low blood sugar hypoglycemia. Please allow up to 10 business days for processing.

Patient Assistance Program: Diabetes Care | Cornerstones4Care®

Heart rate should be monitored at regular intervals consistent with assitsance clinical practice. Acute renal failure and worsening of chronic renal failure, which may sometimes require hemodialysis, have been reported postmarketing, usually in association with nausea, vomiting, diarrhea, or dehydration.

Check your blood sugar levels. For patients with Medicare Part D coverage, an approved application is valid for the benefit year only.

Novo Nordisk assumes no responsibility for any information they may provide. Based on spontaneous ptient reports, acute pancreatitis, including fatal and non-fatal assistznce or necrotizing pancreatitis, has been observed in patients treated with liraglutide.

Website Administered by RxResource. Hypoglycemia is the most common adverse reaction of insulin therapy and may be life-threatening.

Please click the link below to change your password nvoo. After the application is reviewed, you and your patient will be informed of the decision. Indications and Limitations of Use.

Patient Assistance Programs

If a hypersensitivity reaction occurs, discontinue and treat per standard of care. The effect of long-term glycemic control with semaglutide on diabetic retinopathy complications has not been studied. Novo Nordisk will automatically contact the healthcare provider 90 days later to approve the medication refill. Use caution in a patient with a history of angioedema or anaphylaxis with another GLP-1 receptor agonist.

Hypersensitivity and allergic reactions: Get emergency medical help if you have: You may give other people a serious infection, or get a serious patien from them.

Fluid retention and heart failure with concomitant use of PPAR-gamma agonists: A majority of the reported events occurred in patients who had experienced nausea, vomiting, diarrhea, or dehydration. Directory Support Important Links.

1 thoughts on “Novo nordisk patient assistance program”

Leave a Reply

Your email address will not be published. Required fields are marked *